Kempers R D
Mayo Clinic and Mayo Medical School, Rochester, Minnesota, USA.
Hum Fertil (Camb). 2001;4(4):261-6. doi: 10.1080/1464727012000199631.
Peer reviewed biomedical journals are expected to publish accurate and important information. In the process, numerous ethical issues may arise from within both the editorial and the research communities. This article focuses on four general ethical issues: authorship, peer review, duplicate or repetitive publication, and conflict of interest. Issues of authorship include multiple authorship, misconduct among co-authors, guest and honorary authorship, order of authorship, and credit for those not qualifying for authorship. Peer review attempts to ensure that what is published is valid. Ethical issues in peer review include confidentiality of the manuscript, potential editor and reviewer bias, and conflict of interest on the part of the reviewer. Duplicate or repetitive publication, in which the same information is reported two or more times, can damage a journal's reputation for publishing new and important information and can waste its re-sources. Conflicts of interest, in which financial and personal considerations may affect the investigator's personal judgment, can seriously damage the integrity of the author and of the journal. Increased awareness of these ethical issues should stimulate all those involved in the field to take an active role in promulgating and enforcing the highest ethical standards in biomedical publications.
同行评审的生物医学期刊应该发表准确且重要的信息。在此过程中,编辑群体和研究群体内部可能会出现众多伦理问题。本文聚焦于四个常见的伦理问题:作者身份、同行评审、重复发表以及利益冲突。作者身份问题包括多位作者情况、共同作者之间的不当行为、客座和荣誉作者身份、作者顺序以及不符合作者资格者的功劳归属。同行评审旨在确保所发表的内容是有效的。同行评审中的伦理问题包括稿件的保密性、潜在的编辑和审稿人偏见以及审稿人的利益冲突。重复发表,即同一信息被报告两次或更多次,会损害期刊发表新的重要信息的声誉,并可能浪费其资源。利益冲突,即财务和个人因素可能影响研究者的个人判断,会严重损害作者和期刊的诚信。对这些伦理问题的认识提高,应促使该领域的所有相关人员积极参与宣扬和执行生物医学出版物的最高伦理标准。